Trial Profile
Effect of Liraglutide on Fatty Liver Content Evaluated by Proton-spectroscopy (1H-spectroscopy) and Lipoprotein Kinetic, in Patients With Type 2 Diabetes
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2024
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Dyslipidaemias; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LIRA-NAFLD/LIP
- 25 Sep 2020 Results of an in vivo kinetic study presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
- 12 Oct 2016 Results (n=80) assessing effect of liraglutide therapy on liver fat content published in the Journal of Clinical Endocrinology and Metabolism
- 16 Sep 2016 Results of invivo kinetic study presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes